LEONHARDT VENTURES NEWS
Pancreacell Presents Updated Design For Total Pancreas Regeneration At Chicago Conference
October 19th, 2016 - Chicago, IL - PancreaCell a Leonhardt Ventures Co. incubating in the Leonhardt's Launchpads Utah organ regeneration innovation accelerator in Salt Lake City, Utah presented today at the Annual Pancreatic Disorders and Treatment Conference in...
CerebraCell Unveils “Brain Saving” Helmet for Rapid Stroke Recovery
August 5th, 2016 - Santa Monica, CA and Salt Lake City, UT - CerebraCell a Leonhardt Ventures Co. released today that it has filed a provisional patent application for a "brain saving" helmet to help minimize the damage from strokes. Here is a link to a video...
Leonhardt Ventures to Hold Technology Showcase in Conjunction with the 22nd Annual San Diego Heart Failure Symposium
Co-Sponsored by HealthiosXchange Saturday June 18, 2016 @ 2pm Estancia Hotel - To Register email Sofia J. Yepes at sofiacalx@gmail.com and she will send by return email the exact conference room meeting place within the hotel June 17th, Santa Monica, CA - Leonhardt...
Device to Cut Orthodontic Treatment Time in Half – Leonhardt Ventures and OrthodontiCell File Provisional Patent Application
Santa Monica, CA and Salt Lake City, Utah, April. 20th, 2016 - PRBuzz - Leonhardt Ventures -- a developer, manufacturer and marketer of advanced organ regeneration products -- has announced the expansion of its intellectual property portfolio via its startup...
Leonhardt Ventures and CerebraCell File Patent Application for BioElectric Signals to Halt Tumor Growth and Regenerate Organs
– Signals for stopping cell division and halting blood flow to tumors followed by full regeneration program – Press Release – Santa Monica, CA and Salt Lake City, UT – April 14th, 2016 – Leonhardt Ventures and its spin out startups CerebraCell, PancreaCell, RegenaLung...
IGF-1 Controlled Release by Bioelectric Stimulation Provisional Patent Filed by Leonhardt Ventures
Leonhardt Ventures, CerebraCell & BioLeonhardt File Provisional Patent Application For Electrical Stimulation Controlled Release of IGF-1 Key Tool in Regenerating Brains, Hearts, Eyes, Livers, Kidneys, Breasts, Lungs, Pancreas, Skin, Aortas, Heart Valves, Joints,...
Two Entities Seek to Collaborate to Grow Bioscience Startups into Thriving Businesses
Two Entities Seek to Collaborate to Grow Bioscience Startups into Thriving Businesses Los Angeles, California – LABioHub, the Los Angeles-based consortium dedicated to aiding the growth of biomedical enterprises in the region, announced this morning their...
New Larger Venue – Leonhardt Ventures & BioLeonhardt Technology Showcase During ACC Chicago April 2nd, 2016
Leonhardt Ventures & BioLeonhardt Technology Showcase During ACC Chicago April 2nd, 2016 - New Larger Venue Notice Los Angeles, CA, Salt Lake City, UT, Chicago, IL - March 31st, 2016 - Leonhardt Ventures and BioLeonhardt to Present Technology Showcase in Chicago,...
BioLeonhardt Files Provisional Patent Application For Electrical Stimulation Controlled Release Of Follistatin
Santa Monica, CA and Salt Lake City, Utah , Feb. 16th, 2016 /PRBuzz- BioLeonhardt MyoStimwww.bioleonhardt.com funded by Leonhardt Ventures a developer, manufacturer and marketer of advanced organ regeneration products focused on the heart and limbs has announced the...
1H 2016 Newsletter – 2015 Annual Report Summary
Leonhardt Ventures and Cal-X Stars Business Accelerator 1H 2016 Newsletter - 2015 Annual Report Summary Leonhardt Ventures founded 1982* 20+ direct U.S. patents for treating cardiovascular disease & dozens indirect 30 more patents in process or pending. ...